# Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): Moving from targeted therapy to immunotherapy

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/current-who-guidelines-and-the-critical-role-of-immunohistochemical-markers-in/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Lais Osmani,Frederic B. Askin,Edward Gabrielson,Qing Kay Li |
| Citations | 836 |
| DOI | 10.1016/j.semcancer.2017.11.019 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | https://www.ncbi.nlm.nih.gov/pmc/articles/5970946 |
| OpenAlex ID | https://openalex.org/W2769635882 |
| PMID | 29183778 |
| Type | article |
| Year | 2017 |

## Paper authors

- [Frederic B. Askin](https://scholariq.org/researchers/frederic-b-askin/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.